All CHLA Blog Stories

Historically, middle- and higher-income White families and individuals of European ancestry have been the vast majority of participants in clinical trials

Five important questions that parents should ask about participating in a cancer clinical trial.

Born with amniotic band syndrome, Melody is missing some of her fingers and toes. That hasn’t stopped her from embracing her uniqueness and shining in the spotlight.

The Summer Oncology Research Fellowship (SORF) at Children’s Hospital Los Angeles and USC encourages medical students from around the nation to pursue research.

The zebrafish is one of the most powerful biomedical research tools in use today. CHLA is using them to better understand what causes pediatric cancer.

Diagnosed with hepatoblastoma at 17 months old, Aaroh is thriving thanks to chemotherapy and a liver transplant—and the experts at Children’s Hospital Los Angeles who gave him life.

Children’s Hospital is proud to partner with Manos Que Sobreviven (MQS), a local nonprofit that provides food, school assistance and a helping hand to community members in need.

A key study led by Dr. David Freyer showed that sodium thiosulfate prevented cisplatin-related hearing loss in children and led to therapy approval.

CHLA researchers found low-income children and adolescents gained more weight during the pandemic than youth from more affluent families.

Jonathan Santoro, MD, is pioneering a novel treatment—and the first clinical trial— for Down syndrome regression disorder, a devastating condition in young people with Down syndrome.